These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 7150472)

  • 1. Syngeneic antitumour antibodies in rats: clearance of cell-bound antibody in vivo and in vitro.
    Dean CJ; Hobbs SM; Hopkins JU; North SM; Styles JM
    Br J Cancer; 1982 Aug; 46(2):190-7. PubMed ID: 7150472
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Monoclonal antibodies to rat sarcomata. II. A syngeneic IgG2b antibody with anti-tumour activity.
    North SM; Dean CJ
    Immunology; 1983 Aug; 49(4):667-71. PubMed ID: 6874004
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Serological aspects of rat tumour xenograft growth in athymic nude mice.
    Pimm MV; Baldwin RW
    Br J Cancer; 1979 Feb; 39(2):116-21. PubMed ID: 373782
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clearance of antibodies from rat sarcoma cell surfaces. Rate of clearance of alloantibodies depends on antibody isotype.
    Hobbs SM; Styles JM; Dean CJ; Shepherd PS
    Immunology; 1983 Dec; 50(4):565-73. PubMed ID: 6654388
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Soluble tumour-specific antigen and its relationship to tumour growth.
    Thomson DM
    Int J Cancer; 1975 Jun; 15(6):1016-29. PubMed ID: 50290
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Isolation and characterization of a serologically defined tumour membrane antigen from a chemically-induced rat sarcoma, HSN.
    Léger O; Dunn PL; Coles B; Dean CJ
    Int J Cancer; 1991 Feb; 47(4):569-75. PubMed ID: 1704873
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Naturally occurring antibodies against fibrosarcoma and glioma cells in rats.
    Itaya T; Moriuchi T; Kodama T; Sendo F; Kobayashi H
    Gan; 1982 Jun; 73(3):454-61. PubMed ID: 7129010
    [No Abstract]   [Full Text] [Related]  

  • 8. Use of Vaccinia virus as an adjuvant in inducing specific anti-tumour immunity to transplantable mouse fibrosarcoma. II. Rejection of tumour graft 'in vivo' humoral and lymphocytotoxicity 'in vitro'.
    Bendre AR; Gangal SG
    Indian J Cancer; 1978 Dec; 15(4):9-16. PubMed ID: 757692
    [No Abstract]   [Full Text] [Related]  

  • 9. Tumor-bound immunoglobulins. Evidence for the in vivo coating of tumor cells by potentially cytotoxic anti-tumour antibodies.
    Ran M; Klein G; Witz IP
    Int J Cancer; 1976 Jan; 17(1):90-7. PubMed ID: 55397
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Vaccination with syngeneic monoclonal anti-idiotype protects against a tumour challenge.
    Dunn PL; Johnson CA; Styles JM; Pease SS; Dean CJ
    Immunology; 1987 Feb; 60(2):181-6. PubMed ID: 3817870
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Monoclonal antibodies to rat sarcomata. I. Immunization procedures and source of lymphoid cells for hybridoma production.
    North SM; Styles JM; Hobbs SM; Dean CJ
    Immunology; 1982 Nov; 47(3):397-405. PubMed ID: 7129525
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Development of specific cell-dependent antibody during growth of a syngeneic rat sarcoma.
    Basham C; Currie GA
    Br J Cancer; 1974 Mar; 29(3):189-98. PubMed ID: 4830142
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Characterization of syngeneic rat monoclonal antibodies to the HSN tumor using syngeneic monoclonal anti-idiotopic antibodies.
    Léger O; Dean CJ
    J Immunol; 1991 Apr; 146(8):2879-86. PubMed ID: 1901889
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antibodies to tumour eluates react preferentially with non-lymphoid tumours.
    Boyd JE; James K
    Cancer Immunol Immunother; 1983; 15(1):54-8. PubMed ID: 6553508
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dissociation between tumour resistance and delayed-type hypersensitivity to tumour-associated antigens in the mouse.
    Henderson DC; Parker D; Turk JL
    Immunology; 1980 Jan; 39(1):1-9. PubMed ID: 7380461
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Specificity of syngeneic monoclonal antibodies against cell surface antigens of chemically induced mouse fibrosarcomas.
    Klein PA
    Transplant Proc; 1981 Dec; 13(4):1762-4. PubMed ID: 7330965
    [No Abstract]   [Full Text] [Related]  

  • 17. Antibodies and soluble tumour-specific antigens in blood and lymph of rats with chemically induced sarcomata.
    Thomson DM; Eccles S; Alexander P
    Br J Cancer; 1973 Jul; 28(1):6-15. PubMed ID: 4579634
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The serologically unique cell surface antigen of Zajdela ascitic hepatoma is also its tumor-associated transplantation antigen.
    Srivastava PK; Das MR
    Int J Cancer; 1984 Mar; 33(3):417-22. PubMed ID: 6698641
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A syngeneic monoclonal antibody to murine Meth-A sarcoma (HepSS-1) recognizes heparan sulfate glycosaminoglycan (HS-GAG): cell density and transformation dependent alteration in cell surface HS-GAG defined by HepSS-1.
    Kure S; Yoshie O
    J Immunol; 1986 Dec; 137(12):3900-8. PubMed ID: 2431047
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Regulation of serum antibodies induced in syngeneic rats after administration of monoclonal antibody MT10:21.
    North SM; Gurin JL
    Immunology; 1989 Jan; 66(1):26-31. PubMed ID: 15493258
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.